AJANTPHARM.NS Profit & Loss

Ajanta Pharmaceuticals Ltd.

Profit & Loss · 4 years on file (FY2022-23 to FY2025-26) · fetched 2026-08-23 21:33

Line item	FY2022-23	FY2023-24	FY2024-25	FY2025-26	Source (XBRL element)
Revenue from Operations	₹37.43 Bn	₹42.09 Bn	₹46.48 Bn	₹54.53 Bn	RevenueFromOperations
Gross Revenue (incl. inter-segment)	N/A	N/A	N/A	N/A	SegmentRevenueFromOperations
Other Income	₹0.99 Bn	₹0.85 Bn	₹0.94 Bn	₹1.72 Bn	OtherIncome
Total Income	₹38.41 Bn	₹42.93 Bn	₹47.43 Bn	₹56.25 Bn	Income
Cost of Materials Consumed	₹8.78 Bn	₹9.39 Bn	₹8.47 Bn	₹9.17 Bn	CostOfMaterialsConsumed
Purchases of Stock-in-Trade	₹1.46 Bn	₹1.66 Bn	₹2.50 Bn	₹2.30 Bn	PurchasesOfStockInTrade
Changes in Inventories	₹0.26 Bn	₹-0.39 Bn	₹-0.26 Bn	₹0.37 Bn	ChangesInInventoriesOfFinishedGoodsWorkInProgressAndStockInTrade
Employee Benefit Expense	₹7.85 Bn	₹9.00 Bn	₹10.90 Bn	₹12.91 Bn	EmployeeBenefitExpense
Finance Costs	₹0.06 Bn	₹0.07 Bn	₹0.21 Bn	₹0.16 Bn	FinanceCosts
Depreciation and Amortisation	₹1.31 Bn	₹1.35 Bn	₹1.44 Bn	₹1.73 Bn	DepreciationDepletionAndAmortisationExpense
Other Expenses	₹11.24 Bn	₹10.70 Bn	₹12.28 Bn	₹15.83 Bn	OtherExpenses
Total Expenses	₹30.96 Bn	₹31.79 Bn	₹35.53 Bn	₹42.47 Bn	Expenses
Profit Before Exceptional Items and Tax	₹7.45 Bn	₹11.14 Bn	₹11.89 Bn	₹13.78 Bn	ProfitBeforeExceptionalItemsAndTax
Exceptional Items	₹0.00 Bn	₹0.00 Bn	₹0.00 Bn	₹0.00 Bn	ExceptionalItemsBeforeTax
Profit Before Tax	₹7.45 Bn	₹11.14 Bn	₹11.89 Bn	₹13.78 Bn	ProfitBeforeTax
Tax Expense	₹1.57 Bn	₹2.98 Bn	₹2.69 Bn	₹3.22 Bn	TaxExpense
Net Profit (incl. minority interest)	₹5.88 Bn	₹8.16 Bn	₹9.20 Bn	₹10.56 Bn	ProfitLossForPeriod
Net Profit (to shareholders)	₹0.00 Bn	₹8.17 Bn	₹9.20 Bn	₹10.56 Bn	ProfitOrLossAttributableToOwnersOfParent
Basic EPS	₹45.89	₹64.82	₹73.56	₹84.53	BasicEarningsLossPerShareFromContinuingAndDiscontinuedOperations
Diluted EPS	₹45.89	₹64.77	₹73.53	₹84.51	DilutedEarningsLossPerShareFromContinuingAndDiscontinuedOperations

Every figure above is the exact value of the named XBRL element from AJANTPHARM.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).